.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Argus Health
Johnson and Johnson
Federal Trade Commission
McKesson
Healthtrust
AstraZeneca
Fish and Richardson
Deloitte

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091513

« Back to Dashboard

NDA 091513 describes TROSPIUM CHLORIDE, which is a drug marketed by Actavis Labs Fl Inc, Paddock Llc, Upsher-smith Labs, Apotex, Glenmark Generics, Heritage Pharms Inc, and Invagen Pharms, and is included in eight NDAs. It is available from eleven suppliers. Additional details are available on the TROSPIUM CHLORIDE profile page.

The generic ingredient in TROSPIUM CHLORIDE is trospium chloride. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.

Summary for 091513

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Genitourinary Agents

Pharmacology for NDA: 091513

Suppliers and Packaging for NDA: 091513

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091513 ANDA AvKARE, Inc. 42291-846 42291-846-60 60 TABLET in 1 BOTTLE (42291-846-60)
TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091513 ANDA Golden State Medical Supply, Inc. 60429-103 60429-103-60 60 TABLET in 1 BOTTLE (60429-103-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Dec 6, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Queensland Health
Teva
Moodys
McKinsey
Fish and Richardson
Johnson and Johnson
US Department of Justice
Novartis
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot